| Christopher Childers, | |
|
1450 Busch Pkwy Ste 115a, Buffalo Grove, IL 60089-4541 | |
| (224) 676-7920 | |
| (224) 676-7994 |
| Full Name | Christopher Childers |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 6 Years |
| Location | 1450 Busch Pkwy Ste 115a, Buffalo Grove, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013499177 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 070-023748 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Illinois Bone And Joint Institute Llc | 6002814878 | 519 |
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the unblinded results of the first of their 2 placebo-controlled double blind studies in volunteers with their anti-scarring agent RXI-109, a proprietary sd-rxRNA compound that has been shown in vitro and in animals to reduce mRNA for connective tissue growth factor.
Housework is linked to sharper memory, attention span, and better leg strength, and by extension, greater protection against falls, in older adults, finds research published in the open access journal BMJ Open.
Physicians at Mayo Clinic's Individualized Medicine Clinic and researchers at the Translational Genomics Research Institute (TGen) have personalized drug treatments for patients with cholangiocarcinoma using genomic sequencing technologies.
Yesterday, The Lancet published online the results of the first study comparing the once-daily human GLP-1 analog, Victoza (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia. The 26-week trial showed that Victoza produced significantly greater reductions in A1C, fasting plasma glucose, and body weight than Januvia, with similar or better overall treatment satisfaction.
Cancer IO is a new cancer immunotherapy focused top-level collaborative research and innovation project that starts as a part of the Business Finland's Personalized Health Program.
› Verified 5 days ago
| Provider Name | Illinois Bone And Joint Institute Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205922432 PECOS PAC ID: 6002814878 Enrollment ID: O20061110000331 |
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the unblinded results of the first of their 2 placebo-controlled double blind studies in volunteers with their anti-scarring agent RXI-109, a proprietary sd-rxRNA compound that has been shown in vitro and in animals to reduce mRNA for connective tissue growth factor.
Housework is linked to sharper memory, attention span, and better leg strength, and by extension, greater protection against falls, in older adults, finds research published in the open access journal BMJ Open.
Physicians at Mayo Clinic's Individualized Medicine Clinic and researchers at the Translational Genomics Research Institute (TGen) have personalized drug treatments for patients with cholangiocarcinoma using genomic sequencing technologies.
Yesterday, The Lancet published online the results of the first study comparing the once-daily human GLP-1 analog, Victoza (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia. The 26-week trial showed that Victoza produced significantly greater reductions in A1C, fasting plasma glucose, and body weight than Januvia, with similar or better overall treatment satisfaction.
Cancer IO is a new cancer immunotherapy focused top-level collaborative research and innovation project that starts as a part of the Business Finland's Personalized Health Program.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Childers, 900 Rand Rd Ste 300, Des Plaines, IL 60016-2359 Ph: (847) 324-3976 | Christopher Childers, 1450 Busch Pkwy Ste 115a, Buffalo Grove, IL 60089-4541 Ph: (224) 676-7920 |
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the unblinded results of the first of their 2 placebo-controlled double blind studies in volunteers with their anti-scarring agent RXI-109, a proprietary sd-rxRNA compound that has been shown in vitro and in animals to reduce mRNA for connective tissue growth factor.
Housework is linked to sharper memory, attention span, and better leg strength, and by extension, greater protection against falls, in older adults, finds research published in the open access journal BMJ Open.
Physicians at Mayo Clinic's Individualized Medicine Clinic and researchers at the Translational Genomics Research Institute (TGen) have personalized drug treatments for patients with cholangiocarcinoma using genomic sequencing technologies.
Yesterday, The Lancet published online the results of the first study comparing the once-daily human GLP-1 analog, Victoza (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia. The 26-week trial showed that Victoza produced significantly greater reductions in A1C, fasting plasma glucose, and body weight than Januvia, with similar or better overall treatment satisfaction.
Cancer IO is a new cancer immunotherapy focused top-level collaborative research and innovation project that starts as a part of the Business Finland's Personalized Health Program.
› Verified 5 days ago
Brenden Frank, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1450 Busch Pkwy Ste 115a, Buffalo Grove, IL 60089 Phone: 224-676-7960 Fax: 224-676-7994 | |
Agape Health Services Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 604 Buckthorn Ter, Buffalo Grove, IL 60089 Phone: 630-935-6756 | |
Jess Brown, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1156 W Lake Cook Rd, Buffalo Grove, IL 60089 Phone: 847-520-7264 Fax: 847-520-7290 | |
Mrs. Jeanie Chung Kim, M.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 W Half Day Rd, Suite 207, Buffalo Grove, IL 60089 Phone: 847-955-0326 | |
Hetalben Ashish Mehta, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 289 Woodstone Cir, Buffalo Grove, IL 60089 Phone: 224-436-4489 | |
Andrew Vander Zwaag, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1450 Busch Pkwy Ste 115a, Buffalo Grove, IL 60089 Phone: 224-676-7960 Fax: 224-676-7994 |